Transplant Flashcards

1
Q

1 malignancy following any transplant; #2?

A

1 squamous cell skin Ca; #2 = post transplant lymphoproliferative disorder (PTLD – EBV related)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

mechanism of cellcept; main side effect

A

mycophenolate – inhibits T cell growth; can cause myelosuppression, similar to azathioprine (imuran)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

mechanism of cyclosporine? main side effects

A

binds cyclophilin protein, inhibits genes for cytokine synthesis (IL2, IL4 etc.), side effect = nephrotoxicitiy, hepatotoxicity, tremors, seizures, HUS – need careful pharma monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mechanism of FK-506? main side effects

A

prograf/tacrolimus – finds FK binding protein, similar to cyclosporine, inhibits genes for cytokine synthesis; side effects = nephrotoxicity, more GI symptoms/ mood changes than cyclosporine – less rejection episodes in kidney TXPs w/ tac vs CSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

causes of hyperacute rejection

A

caused by preformed antibodies that should have been picked up by cross match, activates complement cascade and thrombosis of vessels occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

cause of accelerated rejection <1 wk

A

caused by sensitized T cells to DONOR antigens – tx w/ increasing immunosuppression and pulse steroids, possible antibody tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

cause of acute rejection (1 wk to 1 month)

A

caused by T cells – cytotoxic/helper T cells; tx w/ increasing immunosuppression, pulse steroids, possible antibody tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

cause of chronic rejection (>1 month)

A

type 4 hypersensitivity reaction (T cell mediated), plus antibody formation – leads to graft fibrosis; tx w/ increased immunosuppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

indication for pancreas transplant

A

1) diabetic pt w/ imminent or established ESRD who have or plan to have kidney txp; OR 2) pt meeting all 3 criteria – frequent episodes of metabolic complication related to diabetes, emotional problems w/ insulin therapy, and conssistnet failure of insulin based management to prevent complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

most significant factor independently associated with death amongst pt awaiting kidney transplant?

A

COPD > smoker status > nonambulatory status > CAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

most common cause of death postop for kidney donors

A

pulmonary emboli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

most common complication for kidney donors postop

A

wound infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

contraindications to organ donation

A

HIV/hepatitis (unless to HIV/hepatitis recipients), cirrhosis, active system infection w/ +blood cultures – cancer often contraindication, depends on the tumor (low grade CNS tumors are often OK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

most common cause of postop oliguria after kidney txp

A

acute tubular necrosis – presents w/ gradual decrease in UOP, usually fluid responsive – if sudden drop in UOP, concern for graft thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

most common cause of extrinsic compression of ureter after kidney txp

A

lymphocele -if asymptomatic do nothing, if symptomatic need image guided drainage or surgical drainage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Post transplant lymphoproliferative disorder: most common type of cell origin? most common after which transplant? Relation to EBV / CMV status?

A

most commonly monoclonal B cell origin, most common after heart/lung transplant vs liver/kidney, EBV negative pt higher risk than EBV positive, CMV negative patients are at increased risk once they seroconvert